Free Trial

Nuvalent (NUVL) News Today

Nuvalent logo
$92.52 +2.10 (+2.32%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$91.26 -1.26 (-1.36%)
As of 10/17/2025 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is Nuvalent Up Today?

Nuvalent, Inc. (NUVL) — Shares moved higher today after fresh analyst coverage and institutional buying pressured the tape upward, while multiple insider stock sales tempered the rally. Below are the items most likely driving the move.

  • Positive Sentiment: New coverage/price targets — Cantor Fitzgerald initiated coverage at Overweight and cited roughly 60% upside, and Stifel Nicolaus reiterated/affirmed a Buy with a $115 target; both boost buy-side interest and headline demand. Source: MSN — Cantor Source: MarketBeat — Stifel
  • Positive Sentiment: Institutional accumulation — MarketBeat notes recent institutional buys and position increases (Voya, BNP Paribas among others), which supports demand and liquidity for the stock. Source: MarketBeat
  • Neutral Sentiment: Analyst momentum overall — multiple firms (Leerink, Piper Sandler, Raymond James, Wedbush) maintain Outperform/Overweight views and higher targets, lifting consensus sentiment even as a small subset remains bearish. Source: MarketBeat
  • Negative Sentiment: Executive and insider selling — CFO Alexandra Balcom sold large blocks (20,000 shares on Oct 13 at ~$88.51 and an additional 1,683 on Oct 15), and insider Henry Pelish sold multiple tranches (7,637 and 2,433 shares). These disclosures (SEC filings) can create short‑term selling pressure or raise governance questions for some investors. Balcom sale (MarketBeat) SEC filing

Bottom line for investors: bullish analyst coverage and institutional inflows appear to be the main drivers of the stock’s uptick today; however, sizeable insider liquidation is a cautionary signal that could cap near-term gains.

Posted 1+ days agoAI Generated. May Contain Errors.

NUVL Latest News

Alexandra Balcom Sells 1,683 Shares of Nuvalent (NASDAQ:NUVL) Stock
Stifel Reiterates Nuvalent (NUVL) Buy Recommendation
Nuvalent (NASDAQ:NUVL) Insider Sells $208,702.74 in Stock
Nuvalent (NASDAQ:NUVL) Insider Henry Pelish Sells 7,637 Shares
Nuvalent (NASDAQ:NUVL) Receives Buy Rating from Stifel Nicolaus
Nuvalent (NASDAQ:NUVL) Insider Sells $208,702.74 in Stock
Cantor Fitzgerald Initiates Coverage on Nuvalent (NASDAQ:NUVL)
Nuvalent (NASDAQ:NUVL) CFO Sells $645,055.88 in Stock
5,700 Shares in Nuvalent, Inc. $NUVL Acquired by Strs Ohio
Nuvalent Completes New Drug Application Submission
Nuvalent (NASDAQ:NUVL) CEO Sells $2,135,160.00 in Stock
Nuvalent (NASDAQ:NUVL) Insider Sells $293,641.75 in Stock
Nuvalent's (NUVL) Outperform Rating Reaffirmed at Wedbush
Nuvalent assumed with a Buy at Guggenheim
Nuvalent, Inc. $NUVL Shares Sold by Northern Trust Corp
Get Nuvalent News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NUVL Media Mentions By Week

NUVL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NUVL
News Sentiment

0.03

0.46

Average
Medical
News Sentiment

NUVL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NUVL Articles
This Week

27

7

NUVL Articles
Average Week

Get the Latest News and Ratings for NUVL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nuvalent and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:NUVL) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners